Opioid sustained-released formulation

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 9/20 (2006.01) A61K 31/135 (2006.01) A61K 31/216 (2006.01) A61K 31/439 (2006.01) A61K 31/451 (2006.01) A61K 31/485 (2006.01) A61K 47/48 (2006.01)

Patent

CA 2379987

A solid, oral, controlled release dosage form comprising a therapeutically effective amount of an opioid compound, or a salt thereof, a matrix-forming polymer and an ionic exchange resin.

L'invention porte sur une forme posologique orale, solide, à libération continue comportant: une quantité à effet thérapeutique d'un composé d'opioïde ou de l'un de ses sels, un polymère en constituant la matrice, et une résine échangeuse d'ions.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Opioid sustained-released formulation does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Opioid sustained-released formulation, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Opioid sustained-released formulation will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1452305

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.